학술논문
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
Document Type
Article
Author
Source
In: Infectious Diseases and Therapy . (Infectious Diseases and Therapy, 2024)
Subject
Language
English
ISSN
21936382
21938229
21938229